21. Myelodysplastic Syndromes myelodysplastic syndromes. The myelodysplastic syndromes have been classifiedinto 5 types according to the FrenchAmerican-British classification. http://www.meb.uni-bonn.de/cancer.gov/CDR0000062929.html

Treatment statement for Health professionals Myelodysplastic Syndromes Get this document via a secure connection General Information Cellular Classification Stage Information ... Previously Treated Myelodysplastic Syndrome General Information The MDS are characterized by abnormal bone marrow and blood cell morphology. Megaloblastic erythroid hyperplasia with macrocytic anemia associated with normal B12 and folate levels is frequently observed. Circulating granulocytes are frequently severely reduced in number, often hypogranular, and display the acquired pseudo Pelger-Huet abnormality. Early, abnormal myeloid progenitors are identified in the marrow in varying percentages, depending on the type of myelodysplastic syndrome. Abnormally small megakaryocytes (micromegakaryocytes) are seen in the marrow and hypogranular or giant platelets appear in the blood. ] Anemia, bleeding, easy bruisability, and fatigue are common initial findings. Splenomegaly or hepatosplenomegaly may occasionally be present. Approximately half of the patients have a detectable cytogenetic abnormality, usually a deletion of all or part of chromosome 5 or 7, or trisomy 8. [ ] Although the bone marrow is usually hypercellular at diagnosis, 15% to 20% of patients present with a hypoplastic bone marrow. [

22. Myelodysplastic Syndromes . What are myelodysplastic syndromes?......Treatment statement for Patients. myelodysplastic syndromes. Get this documentvia a secure connection http://www.meb.uni-bonn.de/cancer.gov/CDR0000062723.html

Treatment statement for Patients Myelodysplastic Syndromes Get this document via a secure connection Description Stage Explanation Treatment Option Overview ... About PDQ Description What are myelodysplastic syndromes? Myelodysplastic syndromes, also called pre-leukemia or "smoldering" leukemia, are diseases in which the bone marrow does not function normally and not enough normal blood cells are made. The bone marrow is the spongy tissue inside the large bones in the body. The bone marrow makes red blood cells (which carry oxygen and other materials to all tissues of the body), white blood cells (which fight infection), and platelets (which make the blood clot). Normally, bone marrow cells called blasts develop (mature) into several different types of blood cells that have specific jobs in the body. Myelodysplastic syndromes occur most often in older people, but they can occur in younger people. The most common sign is anemia, which means there are too few mature red blood cells to carry oxygen. There may also be too few white blood cells in the blood to fight infections. If the number of platelets in the blood is lower than normal, this may cause people to bleed or bruise more easily. A doctor should be seen if a person bleeds without any reason, bruises more easily than normal, has an infection that won't go away, or feels tired all the time. If there are symptoms, a doctor may order blood tests to count the number of each kind of blood cell. If the results of the blood test are not normal, the doctor may do a bone marrow biopsy. During this test, a needle is inserted into a bone and a small amount of bone marrow is taken out and looked at under the microscope. The doctor can then determine the kind of disease and plan the best treatment.

23. Myelodysplastic Syndromes And Sideroblastic Anemias Information on myelodysplastic syndromes, or MDS, and sideroblastic anemias course,symptoms, treatment, psychological and social aspects, caregiving, and http://www.duckandcats.com/

POLICIES HOME FEATURES EVENTS ABOUT BLOOD CAREGIVERS ... CONTACT ME NEW February, 2001: Revamping the website! Check out the updated Resources Page Read my website policies Keep checking back for updated web pages and information! What are MDS and SA? MDS and SA This site is for people affected by MDS and sideroblastic anemias. This includes people who have been diagnosed with these illnesses, and those who care for them, including family and friends. This site provides an overview of how blood works, how MDS and sideroblastic anemias are classified, what their symptoms and course are, their treatment, how they affect people psychologically and socially, including caregivers. I also provide resources for people affected by MDS and sideroblastic anemia, including publications and Internet resources. AA-MDS WebRing This site is part of the AA-MDS WebRing, where people affected by Aplastic Anemia or Myelodysplastic Syndromes share their stories and information.

24. Myelodysplastic Syndromes (MDS), Basic myelodysplastic syndromes (MDS) an overview of MDS symptoms and MDStreatment options. NMDP Home, myelodysplastic syndromes (MDS), basic, http://www.marrow.org/MEDICAL/myelodysplastic_syndromes.html

Home Medical Information Diseases Treatable By Stem Cell Transplant > Myelodysplastic Syndromes (MDS), basic Myelodysplastic Syndromes (MDS), basic Many articles on this Web site are written at two levels: The basic version is written at an introductory level and includes explanations of medical terminology. In the future, an advanced version will contain in-depth information written in the style of a medical journal. Jump to a Section: Symptoms and Diagnosis MDS Treatment Myelodysplastic syndromes (MDS) are a group of diseases that affect the bone marrow and blood. About 12,000 new cases of MDS are diagnosed in the United States each year. Although children and young adults can have MDS, most MDS patients are over age 60. About twice as many men as women have the disease. The cause of MDS is not known, but some studies have linked it to exposure to pesticides, herbicides and the chemical benzene, which is found in unleaded gasoline. MDS is sometimes called myelodysplasia, preleukemia or smoldering leukemia. These last two terms reflect the fact that MDS can sometimes turn into leukemia, most often acute myelogenous leukemia Healthy bone marrow makes stem cells that grow into the three types of blood cells: red blood cells, white blood cells and platelets. In people with MDS, instead of sending red blood cells, white blood cells and platelets into the blood stream, the marrow makes many immature blood cells called blasts. Not only do these blast cells not work normally as red blood cells, white blood cells or platelets, they can also collect in the bone marrow, damaging it even further.

25. Myelodysplastic Syndromes (MDS) - Evaluation, Treatment And Research At The Nati The National Heart, Lung and Blood Institute is actively seeking patients with MyelodysplasticSyndromes (MDS) to receive free evaluation and/or treatment in http://patientrecruitment.nhlbi.nih.gov/MDS.aspx

Patient Recruitment Home Patient Recruitment - Myelodysplastic Syndromes (MDS) Research Studies Stem Cell Transplantation for Older Patients with Leukemias, Lymphomas, and Myelodysplastic Syndromes Treatment of Myelodysplastic Syndromes (MDS) with Antithymocyte Globulin (ATG) and Cyclosporine. Myelodysplastic Syndromes (MDS) Research Study Stem Cell Transplantation for Older Patients with Leukemias, Lymphomas, and Myelodysplastic Syndromes If you are 55 to 75 years of age and have been diagnosed with a leukemia, lymphoma, or myelodysplastic syndrome, you may be eligible for a low-intensity transplant procedure designed to decrease a major transplant complication, graft-versus-host disease (GVHD). Under evaluation is a novel method of treating your donor's cells to selectively remove harmful ones prior to transplant. You must have an HLA-matched brother or sister to participate. We will do the blood testing free of charge to see if your sibling is a match upon request. Eligible patients are not asked to pay for their medical treatment and hospital costs. For more information, please contact our research coordinator at 301-402-0797, email

26. Myelodysplastic Syndromes myelodysplastic syndromes up. Related topics broader, Bone MarrowDiseases. myelodysplastic syndromes, One in a series of booklets http://omni.ac.uk/browse/mesh/detail/C0026986L0026986.html

Myelodysplastic Syndromes [up] Related topics: broader Bone Marrow Diseases other Anemia, Aplastic Myeloproliferative Disorders narrower Hemoglobinuria, Paroxysmal Leukemia, Myeloid Myelodysplastic syndromes One in a series of booklets about leukaemia and related diseases directed at the public. The document covers the types, causes, signs and symptoms, diagnosis, treatment, and prognosis of myelodysplastic syndromes (a group of diseases in which the production of blood cells is disrupted). Published on the web by the Leukaemia Research Fund. Myelodysplastic Syndromes Patient Education Last modified 28/Mar/2003 [Low Graphics]

27. Anomalies ChildMDS Childhood myelodysplastic syndromes. Clinics and Pathology. myelodysplastic syndromesin childhood. Report of 21 patients from Italy and West Germany. http://www.infobiogen.fr/services/chromcancer/Anomalies/childMDS.html

Atlas of Genetics and Cytogenetics in Oncology and Haematology Home Genes Leukemias Solid Tumours ... NA Childhood myelodysplastic syndromes Clinics and Pathology Disease very heterogeneous: I- idiopathic MDS II- secondary MDS: to previous chemo- and/or radio-therapy III- 'genetic MDS': cases associated with a congenital genetic disease, such as: neurofibromatosis type 1 (Von Recklinhausen) (MIM 16220): an hamartoneoplastic syndrome Kostmann syndrome (MIM 20270): also called congenital neutropenia Bloom syndrome (MIM 21090): a chromosome instability syndrome Dubowitz syndrome (MIM 22337): mimicks Bloom's, but without chromosome instability Fanconi anaemia (MIM 22765): a chromosome instability syndrome -Schwachman syndrome (MIM 26040): with pancreatic insufficiency, and risksof leukaemia -Pearson disease (MIM 26056) and other mitochondrial diseases: they often share pancreatic insufficiency, bone marrow pancytopenia with myelodysplastic features but maintained polyclonality, muscular and other ubiquitous manifestations -familial monosomy 7 -familial platelet storage pool deficiency -unbalanced constitutional karyotypes, including +21, +8,del(11q), del(21q) miscellaneous conditions.

28. Cancer And Blood Diseases | Leukemia | Myelodysplastic Syndromes calendar, medical dictionary, news, patient education and other onlineresources. Leukemia, Print Format. myelodysplastic syndromes. http://www.ucsfhealth.org/childrens/medical_services/cancer/leukemia/conditions/

Quick Links... Admissions Appointments Billing Calendar Clinical Trials Clinics Conditions and Treatments Contact a Patient Contact Us Directions and Maps For Health Professionals Jobs Make A Donation Medical Dictionary News Phone Numbers UCSF Medical Center Volunteer Services Cancer and Blood Diseases Topics Leukemia To Visit Us Our Experts ... Other Resources Request an appointment, get directions and phone numbers, find hospital visiting hours and more Choose a doctor from among the 900 experts on our staff Events calendar, medical dictionary, news, patient education and other online resources Leukemia Print Format Myelodysplastic Syndromes Signs and Symptoms Diagnosis Treatment Signs and Symptoms Myelodysplastic syndromes, also called pre-leukemia or "smoldering" leukemia, are diseases in which the bone marrow the spongy tissue inside the large bones does not function normally. Bone marrow cells called "blast" develop or mature into several different types of blood cells including red blood cells that carry oxygen and other materials to all tissues of the body; white blood cells that fight infection; and platelets that make the blood clot. If cells in the bone marrow are injured or abnormal, they may behave abnormally. In myelodysplastic syndromes, the abnormality causes the bone marrow cells or blasts to develop into defective red cells, white cells and platelets. In acute myeloid leukemia, which is the more quickly advancing form of the disease, cells stop maturing altogether.

29. UCSF Children's Hospital | Medical Services | Cancer And Blood Diseases | Leukem myelodysplastic syndromes. Signs and Symptoms. myelodysplastic syndromes,also called preleukemia or smoldering leukemia, are diseases http://www.ucsfhealth.org/childrens/medical_services/cancer/leukemia/conditions/

Myelodysplastic Syndromes Signs and Symptoms Myelodysplastic syndromes, also called pre-leukemia or "smoldering" leukemia, are diseases in which the bone marrow the spongy tissue inside the large bones does not function normally. Bone marrow cells called "blast" develop or mature into several different types of blood cells including red blood cells that carry oxygen and other materials to all tissues of the body; white blood cells that fight infection; and platelets that make the blood clot. If cells in the bone marrow are injured or abnormal, they may behave abnormally. In myelodysplastic syndromes, the abnormality causes the bone marrow cells or blasts to develop into defective red cells, white cells and platelets. In acute myeloid leukemia, which is the more quickly advancing form of the disease, cells stop maturing altogether. Myelodysplastic syndromes or acute myeloid leukemia may arise without any known cause or may be due to prior treatment with drugs or radiation for other diseases. Myelodysplastic syndromes occur most often in older people, but they also occur in children and young people. The name myelodysplastic syndromes is based on how the bone marrow cells and blood cells appear under a microscope. There are five types of myelodysplastic syndromes:

30. Disease Category Listing (516): Myelodysplastic Syndromes (MDS) CenterWatch Listing of Clinical Research Trials for myelodysplastic syndromes(MDS). Clinical Trials myelodysplastic syndromes (MDS). Alabama. http://www.centerwatch.com/patient/studies/cat516.html

Clinical Trials: Myelodysplastic Syndromes (MDS) Alabama Hoover; Clinical Research Consultants Open Label Study of Calcitriol in Transfusion Dependent Myelodysplastic Syndrome Patients California Duarte; City of Hope National Medical Center Randomized, Open-Label, Phase III Trial of Decitabine (5-AZA-2'-Deoxycytidine) Versus Supportive Care in Adults With Advanced-Stage Myelodysplastic Syndrome Duarte; City of Hope National Medical Center Autologous Stem Cell Transplantation for Myelodysplasia in First Remission Stanford; Stanford University - Hematology Division Illinois Chicago; Rush Cancer Institute Open Label Study of Calcitriol in Transfusion Dependent Myelodysplastic Syndrome Patients Chicago; Rush Cancer Institute MDS Center Indiana Indianapolis; Indiana University-Cancer Center Pavilion Massachusetts Wellesley; New England Hematology / Oncology Associates Open Label Study of Calcitriol in Transfusion Dependent Myelodysplastic Syndrome Patients New York Buffalo; Roswell Park Cancer Institute Open Label Study of Calcitriol in Transfusion Dependent Myelodysplastic Syndrome Patients North Carolina Wilmington; PPD Development

31. Study Posting (2200) -- Trial #34520, Myelodysplastic Syndromes (MDS), Wilmingto The Safety And Efficacy Of Thalidomide (Thalomid®) For The Treatment Of Anemia InRed Blood Cell TransfusionDependent Patients With myelodysplastic syndromes. http://www.centerwatch.com/patient/studies/stu34520.html

Trial Information Study Design: A total of 220 patients will be enrolled in this study at approximately 50 centers located in 20 states. Study duration is possible 24 weeks of double-blind treatment followed by a possible additional 24 weeks of open-label treatment. Safety and efficacy assessments will be made at weeks 2, 4 and every 4 weeks thereafter. Inclusion Criteria: Patients are to be diagnosed with myelodysplastic syndrome (FAB criteria) of at least 12 weeks duration with MDS subtype of either refractory anemia (RA), refractory anemia with ring sideroblast (RARS), refractory anemia with excess blasts (RAEB), or chronic myelogenous leukemia. Life expectance of at least 6 months. Patients that are transfusion dependent and transfusion independent may qualify Exclusion Criteria: Pregnant or lactating women and women of childbearing potential who are not using adequate contraception. Prior treatment with thalidomide Participation in another experimental clinical trial within 30 days of the conclusion of screening. Patients with a history of malignancy within 5 years For More Information Regarding This Trial

32. HMDS: The Myelodysplastic Syndromes The myelodysplastic syndromes. FAB CLASSIFICATION OF THE MYELODYSPLASTICSYNDROMES. Morphological Subtype, Peripheral Blood, Bone Marrow. http://www.hmds.org.uk/mds.shtml

Home Page Site Map The Myelodysplastic Syndromes Definition Clinical Features Laboratory Diagnosis Morphology and Trephine Biopsy Histology ... Treatment and Prognosis DEFINITION The myelodysplastic syndromes are acquired clonal disorders of myeloid pluripotent stem cells characterised by morphological abnormalities in the maturing cells of the granulocyte, erythroid and megakaryocyte lineages. Haemopoiesis is ineffective, giving rise to cytopenias. By convention they are separated from the acute myeloid leukaemias on the basis of the percentage of blasts present in the blood and bone marrow. CLINICAL FEATURES The exception is the monosomy 7 syndrome of children. Males affected more frequently than females. Characterised by cytopenias in the peripheral blood (except CMML Symptoms reflect the cytopenias, i.e. anaemia, infection, bruising and haemorrhage. LABORATORY DIAGNOSIS MORPHOLOGY Peripheral Blood Red cells : May show macrocytosis, anisopoikilocytosis and anisochromasia and basophilic stippling, especially in Sideroblastic Anaemia. Nucleated RBC may be present. Neutrophils : May show hypogranular cytoplasm, and abnormal nuclear segmentation; bilobed (spectacle) pseudo-Pelger-Huet nuclei, or round mononuclear nuclei, recognisable as mature by the coarse clumping of the chromatin. Gross hypersegmentation is occasionally present.

33. ACS :: What Are Myelodysplastic Syndromes? myelodysplastic syndromes (MDS) are a group of conditions caused by abnormal bloodformingcells of the bone marrow. What Are myelodysplastic syndromes? http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_myelodysplastic_syn

Home Community Get Involved Donate ... Search GetRandomImage("headerImage", "jpg", 121, 77, 30); My Planner Register Sign In Cancer Reference Information ... Cancer Drug Guide What Is Myelodysplastic Syndrome? Myelodysplastic syndromes (MDS) are a group of conditions caused by abnormal blood-forming cells of the bone marrow. In MDS the bone marrow cannot produce blood cells effectively, and many of the blood cells formed are defective. These abnormal blood cells are usually destroyed before they leave the bone marrow or shortly after entering the bloodstream. As a result, patients have shortages of blood cells, which are reflected in their low blood counts. Although MDS have not been considered cancer in the past, most hematologists (specialists in diseases of the blood) now think it is a form of cancer. The major reason is that it is considered a clonal disease with a single population of abnormal cells. That means that all the cells are exactly alikejust like identical twins. This is often seen in cancer where all the cells have started from an original abnormal cell. A second reason is that in about 30% of MDS cases, the abnormal bone marrow cells eventually progress into

34. ACS :: What Are The Key Statistics About Myelodysplastic Syndromes? It is rare in young adults. As noted in the section What Are MyelodysplasticSyndromes? there are 8 types of MDS. What Are myelodysplastic syndromes? http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics

35. Indiacancer.org - Myelodysplastic Syndromes What are myelodysplastic syndromes? Usually a disease of the older people,myelodysplastic syndromes may also be seen in younger people. http://www.indiacancer.org/coca/m/ms.html

Myelodysplastic Syndromes What is the Bone Marrow? What are Myelodysplastic Syndromes? How do Myelodysplastic Syndromes present? How are Myelodysplastic Syndromes detected? ... What is the importance of follow up? What is the Bone Marrow? The bone marrow is a spongy tissue, which is found mainly in the large bones in the body. The bone marrow is responsible for production of most of the blood's formed elements, which include the red blood cells (carriers of oxygen to all tissues of the body), white blood cells (fighters of infection), and platelets (clotters of blood). Usually, the bone marrow makes cells called blasts that ultimately mature into various types of blood cells, and each of these types of blood cells have specific jobs to do in the body. What are Myelodysplastic Syndromes? These are a rare group of diseases also known as a preleukaemia or smouldering leukaemia , and they are basically diseases of the bone marrow. In these diseases, the bone marrow fails to function normally and an inadequate number of blood cells which are normal, are produced.

36. EMedicine - Myelodysplastic Syndrome : Article By Emmanuel C Besa, MD Aguayo A, Kantarjian H, Manshouri T, et al Angiogenesis in acuteand chronic leukemias and myelodysplastic syndromes. Blood 2000 http://www.emedicine.com/med/topic2695.htm

(advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Medicine, Ob/Gyn, Psychiatry, and Surgery Hematology Myelodysplastic Syndrome Last Updated: April 8, 2002 Rate this Article Email to a Colleague Synonyms and related keywords: MDS, preleukemia, refractory anemia, refractory dysmyelopoietic anemia, smoldering leukemia, subacute myelogenous leukemia, dysmyelopoiesis, refractory anemia, RA, RA with ringed sideroblasts, RARS, RA with excess blasts, RAEB, RAEB in transformation, RAEB-T AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials ... Bibliography Author: Emmanuel C Besa, MD , Professor, Department of Internal Medicine, Division of Hematology and Oncology, Medical College of Pennsylvania Hahnemann University Coauthor(s): Ulrich Woermann, MD , Consulting Staff, Division of Instructional Media, Institute for Medical Education, University of Bern, Switzerland Emmanuel C Besa, MD, is a member of the following medical societies:

37. Myelodysplastic Syndromes Institute. Informationfrom PDQ for Patients. DESCRIPTION. What are myelodysplastic syndromes?......myelodysplastic syndromes. 208/02495. http://cancerweb.ncl.ac.uk/cancernet/202495.html

38. Myelodysplastic Syndromes myelodysplastic syndromes. 208/02495. General months. This type accountsfor approximately 15% to 20% of myelodysplastic syndromes. References http://cancerweb.ncl.ac.uk/cancernet/102495.html

39. KLUWER Academic Publishers Myelodysplastic Syndromes And Myelogenous Leukemia. myelodysplastic syndromes and Secondary AcuteMyelogenous Leukemia Directions for the New Millennium. Add to cart. http://www.wkap.nl/prod/b/0-7923-7396-0

40. Myelodysplastic Syndromes - A Randomized, Multi-Center, Double-Blind, Placebo-Co the Safety and Efficacy of Thalidomide (Thalomid) for the Treatment of Anemia inRed Blood Cell TransfusionDependent Patients with myelodysplastic syndromes. http://www.roswellpark.org/clinicaltrial.asp?lid=1632&reflid=389

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 2     21-40 of 86    Back | 1  | 2  | 3  | 4  | 5  | Next 20